Climate change is affecting the health of all individuals and represents an even more significant health risk for individuals with COPD.

BeiGene has made the decision to end the clinical development program for ociperlimab (BGB-A1217) for the treatment of lung cancer.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Inappropriate Medicare imaging examinations may have produced as many tons of carbon dioxide equivalents as a town of 72,000 people annually.

The WHO's draft agreement, to be approved in May, emphasizes international coordination to improve pandemic preparedness.

Long-term exposure to higher levels of airborne particulate matter and nitrous dioxide is associated with worse performance for cognition.

The FDA will now allow review staff and supervisors to work remotely at least twice weekly after a recent return to office order.

RFK Jr seeks to overturn the CDC's recommendation to fluoridate drinking water and begin investigating fluoride's health risks.

We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and patients.

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains questionable.

Experts expect the NIH funding freeze to reduce new drug development and impede scientists' growth across American research facilities.